May 01, 2020
Medical product distributor Henry Schein Inc. agreed on Thursday to pay $35 million to resolve antitrust and securities fraud claims in a proposed New York federal class action alleging it rigged the prices of dental supplies and artificially inflated share prices by hiding that behavior from shareholders.